patients
microRNA expression in serum exosomes from Caucasian and African American breast cancer patients
…throughput sequencing
Summary
There is drastic racial disparities between Caucasian (CA) and African American (AA) for breast cancer. Circul...
Black, Latino patients underrepresented in ‘high-impact’ cirrhosis clinical trials in US
November 05, 2022
1 min read
Source/Disclosures
Published by:
Source:
Ufere N, et al. Underrepresentation of racial and ethni...
Disparities in Practice Patterns by Sex, Race, and Ethnicity in Patients Referred for Advanced Heart Failure Therapies
. 2022 Oct 21;S0002-9149(22)01007-4.
doi: 10.1016/j.amjcard.2022.09.015.
Online ahead of print.
...
Moffitt study shows genomic testing can identify African American prostate cancer patients with high-risk disease
African American men tend to be diagnosed more frequently with prostate cancer and have higher mortality rates than men of other races and ethnicit...
Barriers to Clinical Trial Participation and Potential Strategies for Enrollment of Hispanic/Latinx Patients With Cancer
Data have demonstrated that Hispanic patients with cancer are often diagnosed at later stages of the disease and have worse quality of life post di...
Minority patients with diabetes likelier to advance to kidney disease
Incidence rate ratios for chronic kidney disease (CKD) among 654,459 patients in the Providence and UCLA health systems with diabetes between 2015 ...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
